Becton, Dickinson And Co.

NYSE:BDX   3:59:54 PM EDT
-3.05 (-1.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)70.22B
Current PE43.91
Forward PE 18.85
2yr Forward PE 18.01
See more stats
Estimates Current Quarter
Revenue$4.88 Billion
Adjusted EPS$3.05
See more estimates
10-Day MA$246.52
50-Day MA$253.46
200-Day MA$245.45
See more pivots

Becton, Dickinson & Co. Stock, NYSE:BDX

1 Becton Drive, Franklin Lakes, New Jersey 07417-1880
United States of America
Phone: +1.201.847.6800
Number of Employees: 72000


Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.